News
MPC Energy Solutions NV (OSL:MPCES) is set to release its Q2 2025 earnings on Jul 31, 2025. The consensus estimate for Q2 ...
Marathon Petroleum Corp. stock grades by Barron's. View MPC fundamental and sentiment analysis powered by MarketGrader.
Cirius Therapeutics shares promising results of MPC Inhibitor 0602K, used alone or with Tirzepatide, highlighting advancements in therapeutic treatments.
Shares of Marathon Petroleum Corp. MPC shed 3.51% to $171.31 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.07% to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback